ACTIVE

MRZK Pharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result35,8 k €+4,9 %over 1 year

Gross margin211,4 k €+24,0 %over 1 year

Equity556,3 k €+6,9 %over 1 year

Workforce2,8 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

MRZK Pharma is a Private limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Hamme (Vl.). It employs on average 2,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0439.203.330
Incorporation: 27/12/1989
Legal form: Private limited company
Registered office: Dorp 11
9220 Hamme (Vl.) · FlandreSee on map
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2025
Average workforce: 2,8 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	211,4 k €	+24.0%	170,5 k €	+20.6%	141,4 k €	-30.8%	204,2 k €	+6.6%	191,5 k €
EBITDA	47,5 k €	+20.5%	39,4 k €	-38.1%	63,7 k €	-46.6%	119,3 k €	-2.1%	121,8 k €
Operating result	41 k €	+20.8%	34 k €	-43.0%	59,6 k €	-48.8%	116,4 k €	-1.9%	118,6 k €
Net result	35,8 k €	+4.9%	34,2 k €	-45.1%	62,2 k €	-39.7%	103,2 k €	+5.4%	97,9 k €
Balance sheet
Equity	556,3 k €	+6.9%	520,4 k €	+7.0%	486,3 k €	-69.8%	1,6 M €	+6.9%	1,5 M €
Total assets	721,1 k €	+5.3%	684,5 k €	+0.4%	682 k €	-61.1%	1,8 M €	+7.7%	1,6 M €
Cash	21,6 k €	-10.4%	24,1 k €	+54.7%	15,6 k €	-12.3%	17,7 k €	+15.9%	15,3 k €
Debts	164,9 k €	+0.5%	164,1 k €	-16.1%	195,7 k €	+36.5%	143,3 k €	+18.0%	121,5 k €
Other
Workforce	2,8 ETP	0.0%	2,8 ETP	+64.7%	1,7 ETP	+6.2%	1,6 ETP	+60.0%	1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ALEXO0870.896.286Represented by Olivier Delaere	Chairman of the board of directorssince 01/09/2022
DEIMOS0866.587.607Represented by Koenraad Clauwaert	Managing directorsince 22/12/2020Manager27/09/2016 → 2019 accountsended
SODIAP0405.366.364Represented by Tom Goderis	Managing directorsince 22/12/2020Manager31/07/2009 → 2015 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ARISTO0434.718.564Represented by Frank Coene	Chairman of the board of directors22/12/2020 → 31/08/2022
Frank Coene	Manager31/07/2009 → 22/12/2020

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/05/2026	16/06/2025	11/06/2024	09/06/2023	07/06/2022	14/06/2021
General meeting	02/05/2026	02/05/2025	03/05/2024	05/05/2023	06/05/2022	07/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	02/05/2026	12/05/2026	Dutch	PDF
Abridged model	31/12/2024	02/05/2025	16/06/2025	Dutch	PDF
Abridged model	31/12/2023	03/05/2024	11/06/2024	Dutch	PDF
Abridged model	31/12/2022	05/05/2023	09/06/2023	Dutch	PDF
Abridged model	31/12/2021	06/05/2022	07/06/2022	Dutch	PDF
Abridged model	31/12/2020	07/05/2021	14/06/2021	Dutch	PDF
Abridged model	31/12/2019	02/05/2020	13/07/2020	Dutch	PDF
Abridged model	31/12/2018	03/05/2019	09/07/2019	Dutch	PDF
Abridged model	31/12/2017	04/05/2018	28/06/2018	Dutch	PDF
Abridged model	31/12/2016	05/05/2017	10/07/2017	Dutch	PDF
Abridged model	31/12/2015	06/05/2016	13/07/2016	Dutch	PDF
Abridged model	31/12/2014	02/05/2015	27/07/2015	Dutch	PDF
Abridged model	31/12/2013	02/05/2014	21/08/2014	Dutch	PDF
Abridged model	31/12/2012	03/05/2013	27/08/2013	Dutch	PDF
Abridged model	31/12/2011	04/05/2012	17/07/2012	Dutch	PDF
Abridged model	31/12/2010	06/05/2011	26/08/2011	Dutch	PDF
Abridged model	31/12/2009	07/05/2010	05/07/2010	Dutch	PDF
Full model	31/12/2008	29/05/2009	29/06/2009	Dutch	PDF
Abridged model	31/12/2007	30/05/2008	25/06/2008	Dutch	PDF
Abridged model	31/12/2006	31/05/2007	28/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 4 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ALEXO0870.896.286Represented by Olivier Delaere	Chairman of the board of directorssince 01/09/2022
DEIMOS0866.587.607Represented by Koenraad Clauwaert	Managing directorsince 22/12/2020Manager27/09/2016 → 2019 accountsended
SODIAP0405.366.364Represented by Tom Goderis	Managing directorsince 22/12/2020Manager31/07/2009 → 2015 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ARISTO0434.718.564Represented by Frank Coene	Chairman of the board of directors22/12/2020 → 31/08/2022
Frank Coene	Manager31/07/2009 → 22/12/2020

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates24/07/2026
Ontslag en benoeming bestuurder
PDF
Mandates02/12/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/01/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Registered office12/06/2018
MAATSCHAPPELIJKE ZETEL
PDF
Mandates13/12/2016
Benoeming zaakvoerder
PDF
Mandates26/05/2010
BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Other20/08/2009
LU
PDF
Mandates30/01/2008
Ontslag van de zaakvoerder - benoeming van nieuwe zaakvoerder -
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

ALEXO

SODIAP

DEIMOS

ARISTO

Frank Coene

APOTHEEK SINT-LODEWIJK

Pierre D'Hollander

19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

MRZK PharmaMRZK Pharma

Dorp 11, 9220 Hamme

Chairman of the board of directors

Managing directorManager

Chairman of the board of directors

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Dorp 11, 9220 HammeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00111151

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
MRZK PharmaCurrent	accounts 2025	Accounts 2025 · 2026-00111151
025 - MRZK Pharma	accounts 2024	Accounts 2024 · 2025-00141140
MRZK Pharma	accounts 2021 → 2023	Accounts 2023 · 2024-00127038

Events

2025
Annual accounts 202535,8 k €↑
2025
Name changeMRZK Pharma
2024
Annual accounts 202434,2 k €↓
2024
Name change025 - MRZK Pharma
2023
Annual accounts 202362,2 k €↓
2022
Annual accounts 2022103,2 k €↑
2021
Annual accounts 202197,9 k €↑
2020
Annual accounts 202062,2 k €↑
2019
Annual accounts 201940,3 k €↓
2018
Annual accounts 201847,7 k €↓
2017
Annual accounts 201751,6 k €↓
2016
Annual accounts 201667,8 k €↓
2015
Annual accounts 201573,8 k €↓
2014
Annual accounts 201475,9 k €↓
2013
Annual accounts 201376,9 k €↑
2012
Annual accounts 201274,9 k €↑
2011
Annual accounts 201148,1 k €↓
2010
Annual accounts 201084,9 k €↑
2009
Annual accounts 200968,2 k €↑
2008
Annual accounts 200823 k €↓
2007
Annual accounts 200776,5 k €↑
2006
Annual accounts 200646,9 k €
27/12/1989
IncorporationPrivate limited company

MRZK Pharma

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events